Kentaro Takayama

Kyoto Pharmaceutical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Amide-to-chloroalkene substitution in CPN-116 increases stability and maintains hNMUR2 agonistic activity and selectivity, overcoming intramolecular acyl transfer on the Dap residue.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Collaborators (5)

Keisuke Hamada

Tokyo University of Pharmacy and Life Sciences

JAPAN

View details

Yoshio Hayashi

Tokyo University of Pharmacy and Life Sciences

JAPAN

View details

Seitaro Fujishima

Director/Associate Professor

Keio University School of Medicine

JAPAN

View details

Sho Konno

Tokyo University of Pharmacy and Life Sciences

JAPAN

View details

Atsuhiko Taniguchi

Tokyo University of Pharmacy and Life Sciences

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kentaro Takayama

Research Interests

Explore related searches

Contact this professor

Articles (13)

Development of Water‐Soluble 3‐Nitro‐2‐Pyridinesulfenate for Disulfide Bond Formation of Peptide Under Aqueous Conditions

Doxorubicin-induced sweet taste sensitivity reduction and compensatory receptor expression in mice

Amide-to-chloroalkene substitution for overcoming intramolecular acyl transfer challenges in hexapeptidic neuromedin U receptor 2 agonists

Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1

Sub-chronic and mild social defeat stress exposure to C57BL/6J mice increases visceral fat mass and causes accumulation of cholesterol and bile acids in the liver

Suppressive Effects of Neuromedin U Receptor 2-Selective Peptide Agonists on Appetite and Prolactin Secretion in Mice

Amide-to-chloroalkene substitution for overcoming intramolecular acyl transfer challenges in hexapeptidic neuromedin U receptor 2 agonists

Precision engineered peptide targeting leukocyte extracellular traps mitigate acute kidney injury in Crush syndrome

Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity

Increasing Skeletal Muscle Mass in Mice by Non-Invasive Intramuscular Delivery of Myostatin Inhibitory Peptide by Iontophoresis

Development of Myostatin Inhibitory d-Peptides to Enhance the Potency, Increasing Skeletal Muscle Mass in Mice

Proposal for the binding mode of the 23-mer inhibitory peptide to myostatin

Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability

Collaborators (5)

Keisuke Hamada

Yoshio Hayashi

Seitaro Fujishima

Sho Konno

Atsuhiko Taniguchi

Make your next move.